-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, A8grJofIywW+MLvGKu93ZuSv51Al+Wh7/eiKSjOGcuKCX7L+UkC0RyOIGidIodh6 /qmkfUSBgw+m6jMlRSda5A== 0001127602-09-023787.txt : 20091130 0001127602-09-023787.hdr.sgml : 20091130 20091130121826 ACCESSION NUMBER: 0001127602-09-023787 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20091112 FILED AS OF DATE: 20091130 DATE AS OF CHANGE: 20091130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MERIDIAN BIOSCIENCE INC CENTRAL INDEX KEY: 0000794172 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 310888197 STATE OF INCORPORATION: OH FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 3471 RIVER HILLS DR CITY: CINCINNATI STATE: OH ZIP: 45244 BUSINESS PHONE: 5132713700 MAIL ADDRESS: STREET 1: 3471 RIVER HILLS DRIVE CITY: CINCINNATI STATE: OH ZIP: 45244 FORMER COMPANY: FORMER CONFORMED NAME: MERIDIAN DIAGNOSTICS INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MOTTO WILLIAM J CENTRAL INDEX KEY: 0000940435 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-14902 FILM NUMBER: 091211188 MAIL ADDRESS: STREET 1: MERIDIAN BIOSCIENCE INC STREET 2: 3471 RIVER HILLS DRIVE CITY: CINCINNATI STATE: OH ZIP: 45244 4/A 1 form4a.xml PRIMARY DOCUMENT X0303 4/A 2009-11-12 2009-11-16 0000794172 MERIDIAN BIOSCIENCE INC VIVO 0000940435 MOTTO WILLIAM J 3471 RIVER HILLS DRIVE CINCINNATI OH 45244 1 1 Executive Chairman Common Stock 2009-11-12 4 D 0 5250 0 D 0 D Common Stock 2009-11-12 4 A 0 5000 0 A 5000 D Common Stock 2009-11-12 4 A 0 5000 0 A 10000 D These restricted shares were granted under the 2004 Equity Compensation Plan and were subject to attainment by the Company of a Net Earnings target for fiscal 2009. As the Company did not reach the target, these restricted shares have been cancelled. These restricted shares are awarded under the 2004 Equity Compensation Plan and vest 25% per year over four years. The first tranche vests on November 12, 2010, subject to attainment of a specified earnings target for fiscal 2010. These restricted shares are awarded under the 2004 Equity Compensation Plan and vest in full (or 100%) on November 12, 2013. This report is being filed to correct the number of shares held directly by Mr. Motto after the November 12, 2009 transactions, which transactions were previously reported on Form 4. /s/ Melissa Lueke as Attorney-in-Fact for William Motto 2009-11-30 -----END PRIVACY-ENHANCED MESSAGE-----